AA
IDYA icon

ALPS Advisors’s IDEAYA Biosciences IDYA Stock Holding History

ALPS Advisors’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.31M Buy
88,769
+17,282
+24% +$529K 0.02% 378
2026
Q1 		$2.38M Sell
71,487
-302
-0.4% -$10.1K 0.01% 372
2025
Q4 		$2.48M Buy
71,789
+29,639
+70% +$945K 0.01% 360
2025
Q3 		$1.15M Sell
42,150
-5,093
-11% -$123K 0.01% 487
2025
Q2 		$993K Sell
47,243
-14,295
-23% -$274K 0.01% 500
2025
Q1 		$1.01M Sell
61,538
-8,354
-12% -$178K 0.01% 471
2024
Q4 		$1.8M Buy
69,892
+5,002
+8% +$142K 0.01% 361
2024
Q3 		$2.06M Buy
64,890
+5,838
+10% +$221K 0.01% 355
2024
Q2 		$2.07M Buy
59,052
+7,071
+14% +$280K 0.01% 331
2024
Q1 		$2.28M Buy
51,981
+9,531
+22% +$410K 0.02% 331
2023
Q4 		$1.51M Sell
42,450
-29
-0.1% -$866 0.01% 378
2023
Q3 		$1.15M Buy
42,479
+368
+0.9% +$9.33K 0.01% 414
2023
Q2 		$990K Buy
+42,111
New +$866K 0.01% 495
2022
Q4 		– Sell
-21,409
Closed -$319K – 1056
2022
Q3 		$319K Sell
21,409
-1,516
-7% -$19.7K ﹤0.01% 696
2022
Q2 		$316K Buy
+22,925
New +$255K ﹤0.01% 760

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

ALPS Advisors's IDYA Position: Q2 2026 in Review

ALPS Advisors increased its IDEAYA Biosciences (IDYA) stake by 24% in Q2 2026, buying an estimated $529K and bringing the position to 88,769 shares worth $3.31M. The position accounts for 0.02% of the portfolio, ranked #378.

ALPS Advisors first reported a position in IDYA in Q2 2022 and has held it in 15 quarters since. 286 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • ALPS Advisors held 88,769 shares of IDEAYA Biosciences worth $3.31M as of Q2 2026.
  • ALPS Advisors bought 17,282 IDEAYA Biosciences shares in Q2 2026, an estimated $529K.
  • IDEAYA Biosciences made up 0.02% of ALPS Advisors's portfolio in Q2 2026, its #378 holding.
  • ALPS Advisors first reported a position in IDEAYA Biosciences in Q2 2022 and has held it in 15 quarters since.
  • 286 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.